DMTK DermTech Inc

Price (delayed)

$75.70

Market cap

$1.48B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.69

Enterprise value

$1.47B

Sector: Healthcare
Industry: Diagnostics & Research

Highlights

The quick ratio has soared by 193% YoY and by 19% from the previous quarter
The revenue has surged by 123% year-on-year and by 17% since the previous quarter
DermTech's equity has soared by 177% YoY but it has decreased by 11% from the previous quarter
The gross margin has soared by 83% YoY but it has contracted by 18% from the previous quarter
The net income has dropped by 73% year-on-year and by 13% since the previous quarter

Key stats

What are the main financial stats of DMTK
Market
Shares outstanding
19.6M
Market cap
$1.48B
Enterprise value
$1.47B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
26.41
Price to sales (P/S)
267.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
274.43
Earnings
Revenue
$5.35M
EBIT
-$30.94M
EBITDA
-$30.6M
Free cash flow
-$29.75M
Per share
EPS
-$1.69
Free cash flow per share
-$1.57
Book value per share
$2.87
Revenue per share
$0.28
TBVPS
$3.01
Balance sheet
Total assets
$57.03M
Total liabilities
$4.78M
Debt
$0
Equity
$52.25M
Working capital
$50.44M
Liquidity
Debt to equity
0
Current ratio
13.31
Quick ratio
12.82
Net debt/EBITDA
0.48
Margins
EBITDA margin
-571.8%
Gross margin
-2%
Net margin
-577.7%
Operating margin
-578.1%
Efficiency
Return on assets
-58.4%
Return on equity
-65%
Return on invested capital
-387.3%
Return on capital employed
-58.5%
Return on sales
-578.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DMTK stock price

How has the DermTech stock price performed over time
Intraday
2.31%
1 week
8.98%
1 month
76.37%
1 year
495.13%
YTD
133.35%
QTD
133.35%

Financial performance

How have DermTech's revenue and profit performed over time
Revenue
$5.35M
Gross profit
-$108,000
Operating income
-$30.94M
Net income
-$30.92M
Gross margin
-2%
Net margin
-577.7%
The revenue has surged by 123% year-on-year and by 17% since the previous quarter
The operating income has plunged by 115% YoY and by 12% from the previous quarter
The gross margin has soared by 83% YoY but it has contracted by 18% from the previous quarter
The net income has dropped by 73% year-on-year and by 13% since the previous quarter

Growth

What is DermTech's growth rate over time

Valuation

What is DermTech stock price valuation
P/E
N/A
P/B
26.41
P/S
267.73
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
274.43
DermTech's EPS has soared by 52% YoY and by 15% from the previous quarter
DermTech's equity has soared by 177% YoY but it has decreased by 11% from the previous quarter
The revenue has surged by 123% year-on-year and by 17% since the previous quarter

Efficiency

How efficient is DermTech business performance
The return on equity has surged by 79% year-on-year and by 6% since the previous quarter
The company's return on assets has surged by 55% YoY and by 4.3% QoQ
DermTech's ROS has increased by 2.1% from the previous quarter and by 2.1% YoY

Dividends

What is DMTK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DMTK.

Financial health

How did DermTech financials performed over time
The quick ratio has soared by 193% YoY and by 19% from the previous quarter
DermTech's current ratio has surged by 186% YoY and by 23% QoQ
DermTech's debt is 100% less than its equity
DermTech's equity has soared by 177% YoY but it has decreased by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.